Home / Market News / $NEOG

$NEOG news and market catalysts

The 15 most recent market catalysts affecting $NEOG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

15 catalysts 4 high impact 12 bullish 1 bearish Life Sciences Tools & Services
Oct 8, 2026 Corporate Catalyst Bullish Impact 75
Why Is Neogen Stock Gaining Thursday?
Neogen's Investor Day presentation outlined a strategic vision extending to fiscal 2031, featuring targets like high-single-digit to low-double-digit revenue growth and a 30% adjus…
Oct 8, 2026 Corporate Catalyst Bullish Impact 85
Reported Earlier, Neogen Outlines Growth And Margin Expansion Strategy At 2026 Investor Day, Targeting High-Single-Digit To Low-Double-Digit Revenue Growth, High-50% Adjusted Gross Margin And 30% Adjusted EBITDA Margin By FY2031
This headline represents a significant corporate catalyst for Neogen. The outlined targets for high-single-digit to low-double-digit revenue growth, high-50% adjusted gross margin,…
Oct 7, 2026 Corporate Catalyst Bullish Impact 75
Neogen Shifts Focus to Scale Profitable Growth
Neogen (NEOG) announced strong first-quarter fiscal year 2027 results, surpassing analyst expectations for both adjusted earnings per share and sales. The company also raised its f…
Oct 7, 2026 Corporate Catalyst Bullish Impact 75
Neogen shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 sales guidance.
Neogen's positive earnings surprise and optimistic long-term guidance are strong indicators of fundamental strength, directly impacting its stock price positively. This performance…
Oct 6, 2026 Corporate Catalyst Bullish Impact 85
Neogen shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 sales guidance.
This headline indicates a strong positive catalyst for Neogen. Better-than-expected financial results demonstrate operational efficiency and demand for their products, while raised…
Oct 6, 2026 Corporate Catalyst Bullish Impact 75
Neogen Raises FY2027 Sales Guidance from $880.000M-$885.000M to $885.000M-$890.000M vs $883.175M Est
Neogen (NEOG) has raised its FY2027 sales guidance from an initial range of $880M-$885M to a new range of $885M-$890M. This upward revision is significant as it surpasses the curre…
Oct 6, 2026 Corporate Catalyst Bullish Impact 92
Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M Estimate
Neogen reported a robust first quarter, with adjusted EPS of $0.08 significantly outperforming the analyst consensus of a $(0.07) loss, representing a 214.29% beat and a 100% incre…
Oct 6, 2026 Corporate Catalyst Bullish Impact 60
Neogen Partners With Hinalea Imaging To Make Digital Imaging Tools For Food Safety, Quality Inspection
Neogen, a leader in food safety, is partnering with and investing in Hinalea Imaging to develop digital imaging tools. This collaboration is a strategic move to integrate emerging …
Sep 30, 2026 Corporate Catalyst Bullish Impact 55
Guggenheim Maintains Buy on Neogen, Raises Price Target to $14
Guggenheim analyst Subbu Nambi maintained a 'Buy' rating on Neogen and raised the price target from $12 to $14. This action signals increased confidence from a prominent financial …
Sep 29, 2026 Corporate Catalyst Bearish Impact 95
Why is Neogen Stock Trading Lower on Tuesday?
Neogen Corp received a formal warning letter from the FDA, citing severe microbiological contamination in its HYCOAT product, which has been directly linked to the largest number o…
Sep 25, 2026 Corporate Catalyst Neutral Impact 65
Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
The filing provides a preview of Neogen's Q1 earnings, scheduled for release on October 6th. Analysts are forecasting a modest increase in EPS from $0.04 to $0.05, but a slight dec…
Aug 26, 2026 Corporate Catalyst Bullish Impact 65
Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
Piper Sandler analyst David Westenberg upgraded Neogen (NEOG) from Neutral to Overweight and raised its price target from $13 to $14. This analyst action signals increased confiden…
Jul 30, 2026 Corporate Catalyst Bullish Impact 75
Neogen shares are trading higher after the company reported better-than-expected Q4 financial results.
This headline indicates a significant positive corporate catalyst for Neogen. Better-than-expected financial results typically lead to increased investor confidence, higher stock p…
Jul 30, 2026 Corporate Catalyst Bullish Impact 75
Neogen Q4 Adj. EPS $0.09 Beats $(0.07) Estimate, Sales $225.300M Beat $212.355M Estimate
Neogen's significant beat on both adjusted EPS and sales is a strong positive signal for the company and potentially the broader agricultural biotechnology sector. The market often…
Jul 30, 2026 Corporate Catalyst Neutral Impact 75
Neogen Sees FY2027 Sales $880.000M-$885.000M vs $849.644M Est
Neogen's disclosure of FY2027 sales guidance ranging from $880 million to $885 million is a significant corporate catalyst. This projection is notably higher than the current analy…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.